Alberta
Alberta based Atlas BiotechnologiesTM invests in leading Oncology Biotech research firm, Flavocure.
Alberta based Atlas BiotechnologiesTM invests in leading Oncology Biotech research firm, Flavocure.
November 06, 2018- Edmonton, Alberta- ?Atlas Biotechnologies Inc. is pleased to announce a 20% investment in Flavocure Biotech, which has an impressive pipeline of oncology research. Flavocure has a patent pending on two therapeutic molecules, which use cannabis flavonoid derivatives in the treatment of three aggressive forms of cancer: AML (Acute Myeloid Leukemia), pancreatic, and glioblastoma (brain) cancer.
“Flavocure is an excellent fit for Atlas Biotechnologies. Our business philosophy is built around curing disease and illness using cannabis derivatives. Flavocure’s FDA orphan drug designation for the treatment of Acute Myeloid Leukemia, combined with their attractive oncology pipeline, made them an obvious choice for collaboration. We intend to jointly develop specialized cannabis cultivars to further unlock the potential of targeted flavonoids in medical research”, said Sheldon Croome, Atlas Biotechnologies CEO.
Flavocure is based in Maryland, USA and collaborates with some of the world’s most prestigious cancer research institutions. The United States Food and Drug Administration (FDA) has approved one of Flavocure’s two proposed therapeutics, Cresorol, with an orphan-drug designation.
Dr. Henry Lowe, an industry pioneer of cannabis phytopharmaceuticals and Flavocure’s founder and Executive Chairman, added, “Our early success in finding cannabis derived molecules for new therapeutic cancer discoveries attracted the interest of a great partner in Atlas. We are very much looking forward to collaborating with them on our genetics program and other drug research programs in the field.”
As part of the integral future collaboration, Atlas will hold a seat on Flavocure’s initial 7-member Board of Directors. Jeffrey R. Gossain, P.Eng, VP of Operations and one of Atlas’ founding Directors will aid in the development of the operational and corporate structure at Flavocure.
Atlas plans to develop a breeding program dedicated to isolating additional molecules in the flavonoid spectrum and identifying further cannabinoids for potential research and supply for future drug commercialization.
About Atlas Biotechnologies Inc. and Atlas Growers Ltd.
Atlas is based in Edmonton, Alberta, Canada and its wholly owned subsidiary, Atlas Growers Ltd., is federally licensed for Cultivation and Production of medical cannabis products. Phase one of Atlas’ purpose-built, 38,000 square foot laboratory has the capacity to produce over 5,000 kg of dried cannabis annually as well as refined cannabis into isolated concentrates in mass capacity. Atlas Growers owns a 160-acre site that could allow for significant future expansion of cultivation capacity in Alberta and has a development permit in place for up to 1,000,000 square feet of additional construction. Atlas also owns 50% of Coastline Biotechnologies, which is a late stage applicant with Health Canada. Coastline anticipates to be licensed for cultivation on Vancouver Island in late 2019. Atlas is well financed, raising over $25.6 million in equity to date, including $7.6 million related to acquisition of land and strategic investments. Atlas also has available for future use a largely unutilized $6.25 million bank term loan.
Alberta
Official statement from Premier Danielle Smith and Energy Minister Brian Jean on the start-up of the Trans Mountain Pipeline
Minister of Municipal Affairs Ric McIver issued the following statement in response to Calgary City Council’s vote to extend the right to vote to permanent residents:
“Yesterday, Calgary city council passed a motion advocating for permanent residents to be extended the right to vote in civic elections. Alberta’s government has been clear since the beginning: only Canadian citizens are able to vote in civic elections. That will not be changing.
“The Canadian Charter of Rights and Freedoms affirms the right of every Canadian citizen to vote and to run as a candidate. This right extends to voters in municipal, provincial and federal elections.
“Protecting our democracy is of the utmost importance. Our provincial election legislation, like the Local Authorities Elections Act, has also been clear since its inception that voting is a right of Canadian citizens.
“Alberta’s government is also ensuring that voting is accessible for more Albertans. The Municipal Affairs Statutes Amendment Act proposes to enable special ballot access for any voter who requests it, without having to provide any specific reason such as physical disability, absence from the municipality or working for the municipal election. The ministries of Seniors, Community and Social Services and Service Alberta and Red Tape Reduction are also making it easier for individuals to obtain the identification Albertans need for a variety of services, including the ability to cast a ballot.
“Our government will continue to protect the integrity of our elections and make sure voting is accessible for all Albertans who are Canadian citizens.”
WHO Official Admits the Truth About Passports
A Coup Without Firing a Shot
Coyotes Ugly: The Sad Obsession Of Gary Bettman
Anti-LNG activists have decided that they now actually care for LNG investors after years of calling to divest
-
Education24 hours agoSupport a young reader through the Tim Hortons Smile Cookie campaign
-
Alberta2 days agoAlberta’s vision for passenger rail
-
John Stossel2 days agoWhy Biden’s Just Wrong: NO ONE “Knows How to Make Government Work.”
-
Education2 days agoRebels earn Jim Donlevy Memorial Trophy as WHL Scholastic Team of the Year
-
RCMP2 days agoRed Deer RCMP arrest two individuals following ramming of police vehicle
-
COVID-192 days agoStates move to oppose WHO’s ‘pandemic treaty,’ assert states’ rights
-
Alberta2 days agoThree Calgary massage parlours linked to human trafficking investigation
-
Business24 hours agoWEF panelist suggests COVID response accustomed people to the idea of CBDCs